Saturday, April 27, 2024

Partner Profiles

anti-cancer vaccine

ARM-002TM anti-cancer vaccine shows promise in combatting pre-established melanoma

Defence Therapeutics Inc. has unveiled the exceptional efficacy of its second-generation ARMTM anti-cancer vaccine. The anti-cancer vaccine, dubbed ARM-002TM, has demonstrated proficiency in combating pre-established...
Chiesi Group

Chiesi Group celebrates €3bn sales success in 2023

Chiesi Group, a renowned biopharmaceutical powerhouse headquartered in Parma, Italy, revealed €3bn in sales in 2023, a significant growth from the previous year. With 31...
ACT label

B Medical Systems’ TCW40SDD receives ACT label from My Green Lab

B Medical Systems, an industry leader in the medical cold chain sector, has received the prestigious ACT label from My Green Lab for its...


Pin It on Pinterest